With A Powerful Client Base And An All-in-one Package, The Contract R&D Firm Syngene Is Galloping Ahead And Now Even Into Manufacturing.
When explaining the core business of Syngene International, its CEO, Jonathan Hunt, offers an interesting analogy. “Think of it as a lock and key. We first spend time understanding the lock (i.e. the disease), and then design the key (i.e. medicine). This is really the first step to building a new medicine and the journey can take about ten years,” he says. With its strong capabilities in discovery and development, Syngene offers its clients a time-saving and cost-efficient way for conducting their research and development (R&D).
The Bengaluru-based company was incorporated in 1993 as a subsidiary of Biocon and started off as a contract research organisation (CRO) with services in chemistry and biology. Over the past 25 years, it has expanded into a leading CRO, which offers R&D programmes ranging from lead generation to clinical supplies (see: The complete package). The company has about 4,000 scientists operating out of their 1,300,000 sq ftCRO facility in India, serving about 331 clients globally. Its prestigious client list — comprising but not restricted to pharmaceuticals, biopharmaceuticals, nutraceuticals, animal health and agrochemicals — includes leading global firms such as Bristol-Myers Squibb (BMS), Zoetis, GlaxoSmithKline (GSK), Abbott, Baxter International, Herbalife Nutrition and Amgen.
“Our clients judge us by the company we keep and the ‘company’ we keep are of world leaders in their field,” says Hunt. Over the past five years, the company sales has grown at a CAGR of 22% to 18.26 billion in FY19. In the same period, net profit grew at 20% to 3.3 billion (see: Healthy growth).
この記事は Outlook Business の May 24, 2019 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、8,500 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は Outlook Business の May 24, 2019 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、8,500 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン
THE JOY OF ADJUSTING A LITTLE
Partha DeSarkar, executive director and CEO of Hinduja Global Solutions, not only advocates making small adjustments but also taking oneself less seriously to remain happy
MONEY PLANT
Firms are popping up to help people and companies plant saplings. Reasons for this green consciousness range from earning carbon credits to a desire to fight deforestation
AI'S NEW PORN POSITION
Deepfakes and artificial intelligence-generated images have breathed new life into the porn industry. Celebrities have become the latest victims and revenge porn is on the rise
HOUSE OF CARDS
At 8.4%, India’s GDP surpassed the expectations of analysts of almost all dispositions. But are GDP numbers hiding a bleaker story? It is not just the missing private money, there are more devils in the story
'Markets Can See More Price Correction in the Coming Quarters'
Sunil Koul, executive director Asia Pacific portfolio strategy, global macro research) at Goldman Sachs, in an exclusive interview with Ayaan Kartik and Neeraj Thakur, talks about the valuation situation in India and how foreign investors are looking at increasing their bets in the equity markets
MARKETS, RETAIL INVESTORS TANGO TO NEW HIGHS
As more investors enter the markets, the palette of investing style becomes more colourful. Each investor brings in their own biases, impulsive actions and assumptions to the markets.
GREED OVER FUNDAMENTALS: THE INVESTOR'S FOLLY
In her address at the fifth SEBI-NISM research conference on March 12, 2024, Securities and Exchange Board of India (SEBI) chief Madhabi Puri Buch expressed her concerns about the valuation froth in the mid- and small-cap space.
WINNING THE GAME OF BULLS AND BEARS
While retail investors rushed to make hay as smalland mid-cap stocks shone at the bourses, institutional investors stayed away, guided by traditional wisdom that warned them against the exuberance in the stock market. The mid-March crash, dominated by the smaller segments, proved their point
DELIRIUM IN THE MARKETS
Market regulator SEBI says there is froth” in the mid-and small-cap stocks; banker Uday Kotak says there is no bubble. Caught in this cross-current are traders in small towns who are betting heavily in risky derivatives. What is next for the turbocharged Indian markets and what of the retail investors rallying behind it?
Dynamic Women Achievers
Discover the vibrant narratives of dynamic women achievers breaking barriers and reshaping the landscape across diverse fields. From trailblazing entrepreneurs to influential thought leaders, this article celebrates the resilience, innovation, and impactful contributions of women who defy norms, inspiring a new era of empowerment and progress.